Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6
暂无分享,去创建一个
[1] Y. Kanfi,et al. Characterization of physiological defects in adult SIRT6-/- mice , 2017, PloS one.
[2] T. Behl,et al. Downregulated Brain-Derived Neurotrophic Factor-Induced Oxidative Stress in the Pathophysiology of Diabetic Retinopathy. , 2017, Canadian journal of diabetes.
[3] T. Arendt,et al. Neuroprotective Functions for the Histone Deacetylase SIRT6. , 2017, Cell reports.
[4] Yang Zhang,et al. SIRT6 protects against palmitate-induced pancreatic β-cell dysfunction and apoptosis. , 2016, The Journal of endocrinology.
[5] R. Coppari,et al. Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6 , 2015, Molecular metabolism.
[6] Facundo H. Prado Spalm,et al. Sphingosine-1-Phosphate Is a Crucial Signal for Migration of Retina Müller Glial Cells. , 2015, Investigative ophthalmology & visual science.
[7] K. Ross,et al. The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine , 2015, Nature Cell Biology.
[8] G. Paolisso,et al. Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment , 2014, Diabetes.
[9] K. Ross,et al. SIRT6 Is Required for Normal Retinal Function , 2014, PloS one.
[10] A. Paterson,et al. Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes , 2014, Diabetes.
[11] T. Gardner,et al. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment , 2014, Annals of the New York Academy of Sciences.
[12] Ian Y. Wong,et al. Ocular Anti-VEGF Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications , 2014, Diabetes Care.
[13] Cristina Hernández,et al. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives , 2014, Trends in Endocrinology & Metabolism.
[14] Sharon D. Solomon,et al. VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy , 2013, Diabetes.
[15] Lei Zhong,et al. SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. , 2013, Molecular cell.
[16] M. Mello,et al. Effects of hyperglycemia and aging on nuclear sirtuins and DNA damage of mouse hepatocytes , 2013, Molecular biology of the cell.
[17] D. Golombek,et al. Effect of Experimental Diabetic Retinopathy on the Non-Image-Forming Visual System , 2013, Chronobiology international.
[18] A. Regev,et al. The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism , 2012, Cell.
[19] U. Lindblad,et al. Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy , 2011, Documenta Ophthalmologica.
[20] K. Lanoue,et al. The influence of diabetes on glutamate metabolism in retinas , 2011, Journal of neurochemistry.
[21] Renu A Kowluru,et al. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon , 2010, Journal of cellular biochemistry.
[22] R. Natarajan,et al. The role of epigenetics in the pathology of diabetic complications. , 2010, American journal of physiology. Renal physiology.
[23] R. Kowluru,et al. Metabolic memory in diabetes – from in vitro oddity to in vivo problem: Role of Apoptosis , 2010, Brain Research Bulletin.
[24] Orian S. Shirihai,et al. The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α , 2010, Cell.
[25] L. Lanting,et al. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes , 2008, Proceedings of the National Academy of Sciences.
[26] H. D. Vanguilder,et al. Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina , 2008, The European journal of neuroscience.
[27] Allen R Kunselman,et al. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.
[28] W. Green,et al. Microglial activation in human diabetic retinopathy. , 2008, Archives of ophthalmology.
[29] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[30] Peter Wiedemann,et al. Müller cells in the healthy and diseased retina , 2006, Progress in Retinal and Eye Research.
[31] Pingfang Liu,et al. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.
[32] P. De Meyts,et al. Role of histone and transcription factor acetylation in diabetes pathogenesis , 2005, Diabetes/metabolism research and reviews.
[33] A. Reichenbach,et al. VEGF release by retinal glia depends on both oxygen and glucose supply , 2000, Neuroreport.
[34] L. Aiello,et al. Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.
[35] F. Cipollone,et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[36] P. Campochiaro,et al. Neurotrophic factors cause activation of intracellular signaling pathways in Müller cells and other cells of the inner retina, but not photoreceptors. , 2000, Investigative ophthalmology & visual science.
[37] T. Gardner,et al. Retinal neurodegeneration: early pathology in diabetes , 2000, Clinical & experimental ophthalmology.
[38] T. Gardner,et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.
[39] A. Barber,et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. , 1998, Diabetes.
[40] G. Kieselbach,et al. Electrophysiological changes in juvenile diabetics without retinopathy. , 1990, Archives of ophthalmology.
[41] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.